AG
CGEM icon

Algert Global’s Cullinan Oncology CGEM Stock Holding History

Algert Global’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.56M Sell
109,731
-52,770
-32% -$678K 0.02% 765
2025
Q4 		$1.68M Sell
162,501
-73,591
-31% -$664K 0.03% 752
2025
Q3 		$1.4M Buy
236,092
+20,512
+10% +$150K 0.02% 775
2025
Q2 		$1.62M Sell
215,580
-5,850
-3% -$47K 0.03% 692
2025
Q1 		$1.68M Buy
221,430
+178,138
+411% +$1.71M 0.04% 651
2024
Q4 		$527K Buy
43,292
+3,408
+9% +$49K 0.01% 896
2024
Q3 		$668K Hold
39,884
– – 0.02% 840
2024
Q2 		$696K Sell
39,884
-39,796
-50% -$847K 0.02% 784
2024
Q1 		$1.36M Buy
79,680
+38,660
+94% +$597K 0.05% 537
2023
Q4 		$418K Buy
41,020
+24,480
+148% +$217K 0.02% 870
2023
Q3 		$150K Buy
+16,540
New +$172K 0.01% 994

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return